Global firms betting on US manufacturing amid tariff threats are facing renewed uncertainty. While promised job growth stalls, Apple, pharma giants, and others now question the viability of shifting supply chains. With tariffs unlikely to drop soon and trade deals in limbo, businesses-and workers-are feeling the strain of a volatile policy landscape.